| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of nab-paclitaxel in a heavily-pretreated breast cancer patient who experienced a change of tumour biology
|
Pluschnig, Ursula
|
|
2014
|
|
Suppl 7 |
p. 119-121
|
artikel
|
| 2 |
Acute lymphoblastic leukemia at the 2023 ASH meeting
|
Böhm, Alexandra
|
|
|
|
Suppl 7 |
p. 168-171
|
artikel
|
| 3 |
Acute myeloid leukaemia (AML) and allogeneic haematopoietic stem cell transplantation
|
Nachbaur, David
|
|
2009
|
|
Suppl 7 |
p. 104-107
|
artikel
|
| 4 |
A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 11–14, 2021
|
|
|
|
|
Suppl 7 |
p. 13-35
|
artikel
|
| 5 |
A histology-based algorithm in the molecular diagnosis of mutations of the epidermal growth factor receptor (EGFR)–in non-small-cell lung cancer (NSCLC)*
|
Popper, H.
|
|
2011
|
|
Suppl 7 |
p. 248-253
|
artikel
|
| 6 |
Angiogenesis as a therapeutic target in advanced breast cancer
|
Stöger, H.
|
|
2008
|
|
Suppl 7 |
p. 9-12
|
artikel
|
| 7 |
Announcement
|
|
|
2008
|
|
Suppl 7 |
p. 47-48
|
artikel
|
| 8 |
Appraisal of recent knowledge in primary central nervous system lymphoma
|
Marturano, Emerenziana
|
|
2012
|
|
Suppl 7 |
p. 285-288
|
artikel
|
| 9 |
ASCO annual meeting 2013: head and neck cancer
|
Pall, Georg
|
|
2013
|
|
Suppl 7 |
p. 240-243
|
artikel
|
| 10 |
ASCO 2017: highlights in breast cancer
|
Bartsch, Rupert
|
|
2017
|
|
Suppl 7 |
p. 228-232
|
artikel
|
| 11 |
ASCO 2013—new concepts and the path to individualized therapy
|
Zwierzina, Heinz
|
|
2013
|
|
Suppl 7 |
p. 251-253
|
artikel
|
| 12 |
ASCO 2018 NSCLC highlights—combination therapy is key
|
Gamerith, Gabriele
|
|
2018
|
|
Suppl 7 |
p. 266-271
|
artikel
|
| 13 |
ASCO update 2016: colorectal cancer
|
Eisterer, Wolfgang
|
|
2016
|
|
Suppl 7 |
p. 222-225
|
artikel
|
| 14 |
ASCO update—hepatocellular carcinoma and cholangiocellular carcinoma
|
Djanani, Angela
|
|
|
|
Suppl 7 |
p. 234-236
|
artikel
|
| 15 |
ASCO update 2015: lung cancer
|
Pall, Georg
|
|
2015
|
|
Suppl 7 |
p. 213-215
|
artikel
|
| 16 |
ASH 2010: new drugs and novel therapeutic concepts on the move
|
Steurer, M.
|
|
2011
|
|
Suppl 7 |
p. 62-63
|
artikel
|
| 17 |
ASH 2011: “Real generosity toward the future lies in giving all to the present”
|
Steurer, Michael
|
|
2012
|
|
Suppl 7 |
p. 167-168
|
artikel
|
| 18 |
Assessment of nutritional status using objective and subjective methods in Greek patients with cancer
|
Vamvakari, Konstantina
|
|
|
|
Suppl 7 |
p. 200-207
|
artikel
|
| 19 |
Autologous stem cell transplantation in light-chain amyloidosis
|
Böhm, Alexandra
|
|
|
|
Suppl 7 |
p. 111-114
|
artikel
|
| 20 |
Best of ASCO 2020
|
Preusser, Matthias
|
|
|
|
Suppl 7 |
p. 7-8
|
artikel
|
| 21 |
Best of ASCO 2021—bladder cancer
|
Mayrhofer, Karl
|
|
|
|
Suppl 7 |
p. 335-337
|
artikel
|
| 22 |
Bevacizumab in recurrence or progress of high-grade gliomas
|
Maier, R.
|
|
2009
|
|
Suppl 7 |
p. 13-14
|
artikel
|
| 23 |
Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
|
Tanaka, Osamu
|
|
|
|
Suppl 7 |
p. 353-356
|
artikel
|
| 24 |
CAR-T cells in multiple myeloma: current status
|
Steiner, Normann
|
|
|
|
Suppl 7 |
p. 43-49
|
artikel
|
| 25 |
CAR T-cell therapy in diffuse large B-cell lymphoma
|
Hopfinger, Georg
|
|
|
|
Suppl 7 |
p. 32-35
|
artikel
|
| 26 |
CAR T cell therapy in solid tumors: a short review
|
Umut, Öykü
|
|
|
|
Suppl 7 |
p. 143-149
|
artikel
|
| 27 |
Challenges of anemia correction during radiotherapy and chemoradiation
|
Rades, D.
|
|
2012
|
|
Suppl 7 |
p. 35-38
|
artikel
|
| 28 |
Chronic lymphocytic leukemia: ASH update 2014
|
Steurer, Michael
|
|
2015
|
|
Suppl 7 |
p. 159-161
|
artikel
|
| 29 |
Circulating tumor cells and circulating tumor DNA in colon cancer - Zirkulierende Tumorzellen und zirkulierende Tumor-DNA bei Kolonkarzinom
|
Fedyanin, Mikhail
|
|
2016
|
|
Suppl 7 |
p. 88-92
|
artikel
|
| 30 |
Clinical challenges in the management of endocrine side effects of immuno-oncological therapies
|
Wolf, Peter
|
|
|
|
Suppl 7 |
p. 72-75
|
artikel
|
| 31 |
Clinical importance of DNA repair inhibitors in cancer therapy
|
Hosoya, N.
|
|
2009
|
|
Suppl 7 |
p. 9-14
|
artikel
|
| 32 |
Clinicopathological profile of bilateral breast cancer at a tertiary cancer center in South India
|
Lakshmaiah, K. C.
|
|
2014
|
|
Suppl 7 |
p. 157-161
|
artikel
|
| 33 |
Creating the “new normal” post-Coronavirus world—web-communication replacing face-to-face interaction
|
Hilbe, Wolfgang
|
|
|
|
Suppl 7 |
p. 245-246
|
artikel
|
| 34 |
Current and evolving treatment strategies in adult immune thrombocytopenia
|
Bohn, Jan-Paul
|
|
2018
|
|
Suppl 7 |
p. 241-246
|
artikel
|
| 35 |
Current standards in the surgical treatment of pancreatic and small intestinal neuroendocrine tumors
|
Klaiber, Ulla
|
|
|
|
Suppl 7 |
p. 282-286
|
artikel
|
| 36 |
Current state of clinical development of TROP2-directed antibody–drug conjugates for triple-negative breast cancer
|
Marhold, Maximilian
|
|
|
|
Suppl 7 |
p. 129-132
|
artikel
|
| 37 |
Current status of peptide vaccines for cancer immunotherapy in malignant myeloid diseases
|
Greiner, J.
|
|
2008
|
|
Suppl 7 |
p. 223-226
|
artikel
|
| 38 |
Current treatment of gastrointestinal stromal tumours
|
Tzekova, V.
|
|
2010
|
|
Suppl 7 |
p. 47-48
|
artikel
|
| 39 |
Cutaneous melanoma—The benefit of screening and preventive measures
|
Seidl-Philipp, Magdalena
|
|
2019
|
|
Suppl 7 |
p. 235-238
|
artikel
|
| 40 |
Cytomegalovirus retinitis in a child with lymphoblastic lymphoma
|
Ansari, Shahla
|
|
2015
|
|
Suppl 7 |
p. 148-151
|
artikel
|
| 41 |
DA-EPOCH-R: An alternative treatment for high-risk diffuse large B cell lymphoma?
|
Panny, Michael
|
|
2016
|
|
Suppl 7 |
p. 178-182
|
artikel
|
| 42 |
Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic
|
Sramkova, Lucie
|
|
2012
|
|
Suppl 7 |
p. 41-45
|
artikel
|
| 43 |
Development of treatment and clinical results in childhood acute myeloid leukemia in the Slovak Republic
|
Kolenova, Alexandra
|
|
2012
|
|
Suppl 7 |
p. 46-53
|
artikel
|
| 44 |
Development of treatment and clinical results in childhood AML in Austria (1993–2013)
|
Boztug, Heidrun
|
|
2014
|
|
Suppl 7 |
p. 63-74
|
artikel
|
| 45 |
Development of treatment and clinical results in childhood AML in Austria (1993–2013)
|
Boztug, Heidrun
|
|
|
|
Suppl 7 |
p. 63-74
|
artikel
|
| 46 |
Educational no. 3: Cytogenetic analysis (CA)
|
Erdel, Martin
|
|
2018
|
|
Suppl 7 |
p. 257-260
|
artikel
|
| 47 |
Educational no. 4: PCR-based methods
|
Zach, Otto
|
|
2018
|
|
Suppl 7 |
p. 4-6
|
artikel
|
| 48 |
Emerging treatment strategies in chronic B-cell malignancies—News from ICML 2023
|
Bohn, Jan-Paul
|
|
|
|
Suppl 7 |
p. 210-214
|
artikel
|
| 49 |
ESMO 2021—highlights in colorectal cancer
|
Weiss, Lukas
|
|
|
|
Suppl 7 |
p. 114-116
|
artikel
|
| 50 |
ESMO 2020 update: Pancreatic cancer
|
Bergen, Elisabeth Sophie
|
|
|
|
Suppl 7 |
p. 176-179
|
artikel
|
| 51 |
ESMO update: upper gastrointestinal cancer
|
Bergen, Elisabeth S.
|
|
|
|
Suppl 7 |
p. 105-107
|
artikel
|
| 52 |
Excellent response of a disseminated SMARCA4-deficient thoracic sarcomatoid tumor to immunochemotherapy—a case report
|
Petrasch, Clemens
|
|
|
|
Suppl 7 |
p. 122-124
|
artikel
|
| 53 |
First-line treatment of metastatic renal cell carcinoma: current standard of care
|
Marszalek, Martin
|
|
|
|
Suppl 7 |
p. 334-338
|
artikel
|
| 54 |
Gastric cancer – ASCO 2010
|
Wöll, E.
|
|
2010
|
|
Suppl 7 |
p. 168-170
|
artikel
|
| 55 |
Gastric MALT lymphoma
|
Troch, M.
|
|
2009
|
|
Suppl 7 |
p. 130-133
|
artikel
|
| 56 |
Gender differences in quality of life in patients with haematological malignancies
|
Sztankay, M.
|
|
2011
|
|
Suppl 7 |
p. 224-226
|
artikel
|
| 57 |
Healthcare resource utilization and G‑CSF use in patients with solid tumors or hematological malignancies hospitalized for febrile neutropenia in Bulgaria, Czech Republic and Slovakia
|
Mihaylov, Georgi
|
|
2016
|
|
Suppl 7 |
p. 144-152
|
artikel
|
| 58 |
HIV-triggered lymphoma
|
Hartmann, Bernd Lorenz
|
|
2019
|
|
Suppl 7 |
p. 230-234
|
artikel
|
| 59 |
Homologous recombination deficiency: New biomarkers in innovative treatments
|
Singer, Christian F.
|
|
|
|
Suppl 7 |
p. 357-358
|
artikel
|
| 60 |
IMiDs induce pleiotropic anti-cancer effects
|
Wolf, Dominik
|
|
2009
|
|
Suppl 7 |
p. 10-12
|
artikel
|
| 61 |
Immunotherapy revisited
|
Füreder, Thorsten
|
|
|
|
Suppl 7 |
p. 127-128
|
artikel
|
| 62 |
Incidental thyroid papillary microcarcinoma on 1777 surgically treated patients for benign thyroid disease
|
Peluso, Gaia
|
|
|
|
Suppl 7 |
p. 126-133
|
artikel
|
| 63 |
Interventional therapy for symptomatic bronchial carcinoma
|
Geltner, Christian
|
|
2012
|
|
Suppl 7 |
p. 149-153
|
artikel
|
| 64 |
Isolated colonic metastasis from breast cancer 11 years after primary diagnosis
|
Ben Ameur, Hazem
|
|
2013
|
|
Suppl 7 |
p. 149-152
|
artikel
|
| 65 |
Latest progress in treatment of gynaecological cancers
|
Zeimet, A. G.
|
|
2008
|
|
Suppl 7 |
p. 271-275
|
artikel
|
| 66 |
Local therapy of stage IV renal cell cancer: a case report
|
Ferner, Muna
|
|
2018
|
|
Suppl 7 |
p. 38-42
|
artikel
|
| 67 |
Lung cancer screening from the oncologist’s perspective
|
Kocher, Florian
|
|
2019
|
|
Suppl 7 |
p. 175-178
|
artikel
|
| 68 |
Lutetium-PSMA therapy—a new therapeutic option in metastatic castration-resistant prostate cancer?
|
Ladurner, Michael
|
|
2018
|
|
Suppl 7 |
p. 301-304
|
artikel
|
| 69 |
Mechanisms of tumour vascularisation
|
Gehling, U. M.
|
|
2008
|
|
Suppl 7 |
p. 3-7
|
artikel
|
| 70 |
Melanocytic tumour of the spinal dura: case presentation and review of the literature
|
Rössler, K.
|
|
2010
|
|
Suppl 7 |
p. 30-31
|
artikel
|
| 71 |
memo—publisher’s report 2018
|
Sillaber, Alois
|
|
2019
|
|
Suppl 7 |
p. 109-110
|
artikel
|
| 72 |
memo: Spectacular developments during the last decade from the Section Editors’ point of view
|
Hofer, Silvia
|
|
2017
|
|
Suppl 7 |
p. 4-7
|
artikel
|
| 73 |
Metastasis-directed therapy: new standard or too early to change paradigm?
|
Klemm, Jakob
|
|
|
|
Suppl 7 |
p. 45-50
|
artikel
|
| 74 |
Metronomic antiangiogenic therapy in children with recurrent brain tumours of different histologies
|
Peyrl, A.
|
|
2011
|
|
Suppl 7 |
p. 21-23
|
artikel
|
| 75 |
Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO
|
Stenger, I.
|
|
2011
|
|
Suppl 7 |
p. 31-37
|
artikel
|
| 76 |
Molecular profiling in gastroesophageal cancer—clinical routine and future perspective
|
Puhr, Hannah Christina
|
|
|
|
Suppl 7 |
p. 440-444
|
artikel
|
| 77 |
Molecular profiling in lung cancer
|
Nagl, Laurenz
|
|
|
|
Suppl 7 |
p. 201-205
|
artikel
|
| 78 |
My burning issues in the neoadjuvant treatment for breast cancer
|
Bergen, Elisabeth S.
|
|
2017
|
|
Suppl 7 |
p. 27-30
|
artikel
|
| 79 |
Myelodysplastic Syndromes (MDS) – News from ASH 2010
|
Nösslinger, T.
|
|
2011
|
|
Suppl 7 |
p. 110-112
|
artikel
|
| 80 |
Natural killer cell based immunotherapy for eradication of minimal residual disease in patients with malignant disorders
|
Tsirigotis, Panagiotis D.
|
|
2012
|
|
Suppl 7 |
p. 98-100
|
artikel
|
| 81 |
Neoadjuvant treatment of pancreatic ductal adenocarcinoma
|
Kosma, Katharina
|
|
|
|
Suppl 7 |
p. 219-223
|
artikel
|
| 82 |
Optimal surveillance strategy of localised testicular non-germ cell sex-cord stromal tumours
|
Rauf, Muhammad
|
|
2012
|
|
Suppl 7 |
p. 140-143
|
artikel
|
| 83 |
Orbito-maxillofacial mesenchymal chondrosarcoma with intracranial invasion and lung metastasis
|
Sepúlveda, Ilson
|
|
2017
|
|
Suppl 7 |
p. 106-110
|
artikel
|
| 84 |
Paediatric NEWS & NOTES from the 50th annual ASH meeting
|
Breuer, Sabine K.
|
|
2009
|
|
Suppl 7 |
p. 71-73
|
artikel
|
| 85 |
Pancytopenia—a diagnostic challenge?
|
Geissler, Klaus
|
|
|
|
Suppl 7 |
p. 355-359
|
artikel
|
| 86 |
Pathology of gastrointestinal stromal tumours with accent to prognostic criteria
|
Kamenova, M.
|
|
2010
|
|
Suppl 7 |
p. 53-57
|
artikel
|
| 87 |
Patient-reported outcomes and psycho-oncological screening in hematology: a practical example of routine electronic monitoring
|
Lehmann, Jens
|
|
|
|
Suppl 7 |
p. 285-293
|
artikel
|
| 88 |
Personalized medicine – p53 gene analysis for prediction of response to neoadjuvant therapy in esophageal cancer
|
Kandioler, D.
|
|
2008
|
|
Suppl 7 |
p. 137-142
|
artikel
|
| 89 |
Potential impact of the hypomethylating agent 5-azacitidine on chronic lymphocytic leukemia with del(17)(p)/del(p53) and subsequent therapy-related acute myeloid leukemia without these aberrations: a case report
|
Pfeilstöcker, Michael
|
|
2015
|
|
Suppl 7 |
p. 144-147
|
artikel
|
| 90 |
Practice changing information in aggressive lymphoma, ASH 2015
|
Fridrik, Michael A.
|
|
2016
|
|
Suppl 7 |
p. 124-126
|
artikel
|
| 91 |
Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria
|
Balic, Marija
|
|
|
|
Suppl 7 |
p. 290-296
|
artikel
|
| 92 |
Prevention and treatment of febrile neutropenia
|
Weissinger, F.
|
|
2012
|
|
Suppl 7 |
p. 30-34
|
artikel
|
| 93 |
Primary chemotherapy and maintenance therapy in epithelial ovarian cancer
|
Zeimet, A. G.
|
|
2008
|
|
Suppl 7 |
p. 99-102
|
artikel
|
| 94 |
Proceedings of the Annual Meeting of the
|
|
|
2016
|
|
Suppl 7 |
p. 1-34
|
artikel
|
| 95 |
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Oncology
|
|
|
2013
|
|
Suppl 7 |
p. 1-42
|
artikel
|
| 96 |
Progress in the multidisciplinary management of esophageal cancer: what are the latest developments?
|
Winder, Thomas
|
|
2019
|
|
Suppl 7 |
p. 2-3
|
artikel
|
| 97 |
Qualitative and quantitative assessment of endpoints in clinical trials
|
Fridrik, Michael A.
|
|
2010
|
|
Suppl 7 |
p. 33-36
|
artikel
|
| 98 |
Recent developments in the palliative treatment of breast cancer: ASCO 2013
|
Petru, Edgar
|
|
2013
|
|
Suppl 7 |
p. 233-235
|
artikel
|
| 99 |
Recommendations of the Austrian Working Group on Lung Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer
|
Popper, Helmut H.
|
|
2013
|
|
Suppl 7 |
p. 83-91
|
artikel
|
| 100 |
Report from the Virtual Edition of the 25th European Hematology Association (EHA), Annual Congress 11th –21st June 2020
|
|
|
|
|
Suppl 7 |
p. 91-110
|
artikel
|
| 101 |
Report on Lung Cancer from the ASCO 2021 virtual congress, June 4th–8th
|
|
|
|
|
Suppl 7 |
p. 67-89
|
artikel
|
| 102 |
Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab
|
Kauffmann-Guerrero, Diego
|
|
2019
|
|
Suppl 7 |
p. 149-155
|
artikel
|
| 103 |
Role of FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas
|
Vassilakopoulos, Theodoros P.
|
|
2015
|
|
Suppl 7 |
p. 105-114
|
artikel
|
| 104 |
SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis
|
Rinnerthaler, Gabriel
|
|
2018
|
|
Suppl 7 |
p. 208-212
|
artikel
|
| 105 |
Screening and prophylaxis of cancer
|
Rumpold, Holger
|
|
2019
|
|
Suppl 7 |
p. 192-193
|
artikel
|
| 106 |
Short review San Antonio 2016
|
Hubalek, Michael
|
|
2017
|
|
Suppl 7 |
p. 90-93
|
artikel
|
| 107 |
Skin tumours in organ transplant recipients—implications for the plastic surgeon
|
Krapf, Johanna
|
|
2019
|
|
Suppl 7 |
p. 222-224
|
artikel
|
| 108 |
Surgical aspects in the treatment of retroperitoneal soft tissue sarcomas
|
Perathoner, Alexander
|
|
2014
|
|
Suppl 7 |
p. 177-180
|
artikel
|
| 109 |
Sustained remission of adult Langerhans histiocytosis utilizing molecular therapy
|
Doleschal, Bernhard
|
|
|
|
Suppl 7 |
p. 115-118
|
artikel
|
| 110 |
Tailoring treatment in myeloma: are there clues from biology?
|
Zojer, Niklas
|
|
2015
|
|
Suppl 7 |
p. 11-15
|
artikel
|
| 111 |
The future of clinical trials—goals, ideas, and discussion
|
Gnant, Michael
|
|
|
|
Suppl 7 |
p. 77-86
|
artikel
|
| 112 |
The molecular tumor board—a key element of precision oncology
|
Boos, Laura
|
|
|
|
Suppl 7 |
p. 190-193
|
artikel
|
| 113 |
The pathology of low and intermediate neuroendocrine lung tumors
|
Popper, Helmut H
|
|
2012
|
|
Suppl 7 |
p. 22-25
|
artikel
|
| 114 |
Therapeutic options for the treatment of infections with multiresistant grampositive bacteria in oncological patients
|
Fritsche, G.
|
|
2008
|
|
Suppl 7 |
p. 177-180
|
artikel
|
| 115 |
The role of robotic surgery in gynaecological oncology
|
Vasilescu, C.
|
|
2010
|
|
Suppl 7 |
p. 119-122
|
artikel
|
| 116 |
Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report
|
Müser, Nino Rafael
|
|
|
|
Suppl 7 |
p. 107-109
|
artikel
|
| 117 |
Treatment of elderly and very old patients with AML
|
Koller, Elisabeth
|
|
2016
|
|
Suppl 7 |
p. 4-7
|
artikel
|
| 118 |
Treatment results and follow-up after definitive radio-chemotherapy in anal cancer: when to perform biopsies?
|
Becker-Schiebe, Martina
|
|
2014
|
|
Suppl 7 |
p. 115-118
|
artikel
|
| 119 |
Venous thromboembolism in children with acute lymphoblastic leukemia
|
Skalska-Sadowska, Jolanta
|
|
2014
|
|
Suppl 7 |
p. 148-151
|
artikel
|
| 120 |
What is new in the surgical approach for malignant brain tumours
|
Kostron, H.
|
|
2009
|
|
Suppl 7 |
p. 5-7
|
artikel
|
| 121 |
What’s new in Hodgkin’s lymphoma: ASH 2012 and more
|
Melchardt, Thomas
|
|
2013
|
|
Suppl 7 |
p. 193-196
|
artikel
|
| 122 |
WHO classification of tumors of the nervous system: preview of the upcoming 5th edition
|
Rushing, Elisabeth J.
|
|
|
|
Suppl 7 |
p. 188-191
|
artikel
|
Tijdschrift beschrijving